进展期胃癌转移现状及相关分子机制研究进展
Current Status of Multiple Metastases in Advanced Gastric Cancer and Research Progress of Related Molecular Mechanisms
DOI: 10.12677/ACM.2022.123319, PDF,    科研立项经费支持
作者: 刘 韬, 王 成*：青海大学附属医院胃肠外科，青海 西宁
关键词: 胃癌；脏器转移；血管转移；预后；Gastric Carcinoma； Organ Metastasis； Vascular Metastasis； Prognosis
摘要: 胃癌是常见的消化道恶性肿瘤之一，同时也是因肿瘤致死亡的主要原因之一，死亡率位居第二。因胃癌早期患者症状多为隐匿，无明显临床表现，大多数患者对该疾病的认识不清，故临床上诊断胃癌时多为进展期，且多伴有其他重要脏器(肝、骨、脑等)及血管的转移，从而导致胃癌的手术难度明显加大，术后效果欠佳，预后差、病死率高、生存率低。然而目前，胃癌多脏器转移的相关文献较少，且涉及的相关机制尚不明确，故本文通过搜集相关文献对进展期胃癌发生多脏器(肝、骨、脑)及血管转移及涉及相关机制进行归纳，旨在为临床上诊治进展期胃癌提供参考。
Abstract: Gastric cancer is one of the common malignant tumors of the digestive tract, and it is also one of the main causes of death due to tumors. The death rate of gastric cancer ranks second. Because the symptoms of early gastric cancer patients are insidious mostly, and there is no obvious clinical appearance, most patients have unclear understanding of the disease. Therefore, the clinical diagnosis of gastric cancer is advanced mostly, and it is often accompanied by other important organs (liver, bone, brain, etc.), resulting in significantly increased difficulty in gastric cancer surgery, poor postoperative results, poor prognosis, high mortality, and low survival rate. However, at present, there are few related literatures on multi-organ metastasis of gastric cancer, and the related mechanisms are not clear. Therefore, this article collects related literatures on the occurrence of multi-organ (liver, bone, brain) metastasis and related mechanisms in advanced gastric cancer. In summary, it aims to provide a reference for the clinical diagnosis and treatment of advanced gastric cancer.
文章引用：刘韬, 王成. 进展期胃癌转移现状及相关分子机制研究进展[J]. 临床医学进展, 2022, 12(3): 2218-2225. https://doi.org/10.12677/ACM.2022.123319

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] 陈万青, 郑荣寿, 张思维, 曾红梅, 左婷婷, 贾漫漫, 夏昌发, 邹小农, 赫捷. 2012年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2016, 25(1): 1-8.
[3] 孙晓卫, 李威, 刘学超, 詹友庆, 周志伟. 胃癌同时性肝转移预后的多因素分析[J]. 中华肿瘤防治杂志, 2016, 23(21): 1446-1449.
[4] 侯松林, 谢兴江, 彭强, 周国俊, 李利发, 周何, 张广军, 周彤. 基于SEER数据库的胃癌肝转移预后因素分析与预后模型构建[J]. 中国普通外科杂志, 2020, 29(10): 1212-1223.
[5] 侯培锋, 张祥福, 黄昌明, 卢辉山, 王川, 吴心愿, 官国先, 郑知文. 影响早期胃癌预后及淋巴结转移因素分析[J]. 中国肿瘤, 2011, 20(4): 306-308.
[6] 卫勃, 刘国晓. 胃癌肝转移的机制[J]. 中华胃肠外科杂志, 2014, 17(7): 728-729.
[7] Xiao, Y., Zhang, B. and Wu, Y. (2019) Prognostic Analysis and Liver Metastases Relevant Factors after Gastric and Hepatic Surgical Treatment in Gastric Cancer Patients with Metachronous Liver Metastases: A Population-Based Study. Irish Journal of Medical Science, 188, 415-424. [Google Scholar] [CrossRef] [PubMed]
[8] 王兴国, 张亮刚, 杨中民. 胃癌异时性肝转移影响因素及不同治疗方式的效果和预后分析[J]. 中国现代普通外科进展, 2021, 24(2): 99-103.
[9] 饶显平, 郭东阳, 周天华, 卓巍. 胃癌肝转移的分子机制[J]. 中国细胞生物学学报, 2018, 40(1): 7-16.
[10] Lee, P.C., Chiang, J.C., Chen, C.Y., Chien, Y.C., Chen, W.M., Huang, C.W., Weng, W.C., Chen, C.I., Lee, P.H., Chen, C.N. and Lee H. (2019) Calreticulin Regulates Vascular Endothelial Growth Factor—A MRNA Stability in Gastric Cancer Cells. PLoS ONE, 14, Article ID: e0225107. [Google Scholar] [CrossRef] [PubMed]
[11] Mimori, K., Fukagawa, T., Kosaka, Y., Kita, Y., Ishikawa, K., Etoh, T., et al. (2008) Hematogenous Metastasis in Gastric Cancer Requires Isolated Tumor Cells and Exprssion of Vascular Endothelial Growth Factor Receptor-1. Clinical Cancer Research, 14, 2609-2616. [Google Scholar] [CrossRef] 
[12] Lwin, Z.M., Guo, C., Salim, A., Yip, G.W., Chew, F.T., Nan, J., et al. (2010) Clinicopathological Significance of Calreticuli in Breast Invasive Ductal Carcinoma. Modern Pathology, 23, 1559-1566. [Google Scholar] [CrossRef] [PubMed]
[13] Lee, J., Lee, J., Yu, H., Choi, K. and Choi, C. (2011) Differential Dependency of Human Cancer Cells on Vascular Endothelial Growth Factor-Mediated Autocrine Growth and Survival. Cancer Letters, 309, 145-150. [Google Scholar] [CrossRef] [PubMed]
[14] Lee, J., Ku, T., Yu, H., Chong, K., Ryu, S.W., Choi, K., et al. (2012) Blockade of VEGF-A Suppressestumor Growth Via Inhibition of Autocrine Signaling through FAK and AKT. Cancer Letters, 318, 221-225. [Google Scholar] [CrossRef] [PubMed]
[15] Yuan, H., Chen, Z., Bai, S., Wei, H., Wang, Y., Ji, R., Guo, Q., Li, Q., Ye, Y., Wu, J., Zhou, Y. and Qiao L. (2018) Molecular Mechanisms of LncRNA SMARCC2/miR-551b-3p/TMPRSS4 Axis in Gastric Cancer. Cancer Letters, 418, 84-96. [Google Scholar] [CrossRef] [PubMed]
[16] Liu, H.-T., Ma, R.-R., Lv, B.-B., Zhang, H., Shi, D.-B., Guo, X.-Y., Zhang, G.-H. and Gao, P. (2020) LncRNA-HNF1A-AS1 Functions as a Competing Endogenous RNA to Activate PI3K/AKT Signalling Pathway by Sponging MiR-30b-3p in Gastric Cance. British Journal of Cancer, 122, 1825-1836. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, D., Cao, G., Qiao, C., Liu, G., Zhou, H. and Liu, Q. (2018) Alpha B-Crystallin Promotes the Invasion and Metastasis of Gastric Cancer Via NF-κB-Induced Epithelial-Mesenchymal Transition. Journal of Cellular and Molecular Medicine, 22, 3215-3222. [Google Scholar] [CrossRef] [PubMed]
[18] Sánchez-Tilló, E., Liu, Y., De Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D.S., Dean, D.C., Castells, A. and Postigo, A. (2012) EMT-Activating Transcription Factors in Cancer: Beyond EMT and Tumor Invasiveness. Cellular and Molecular Life Sciences, 69, 3429-3456. [Google Scholar] [CrossRef] [PubMed]
[19] Lamouille, S., Xu, J. and Derynck, R. (2014) Molecular Mechanisms of Epithelial-mesenchymal Transition. Nature Reviews Molecular Cell Biology, 15, 178-196. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, X.L., Hong, L.L., Wang, K.L., Liu, X., Wang, J.L., Lei, L., Xu, Z.Y., Cheng, X.D. and Ling, Z.Q. (2019) Deregulation of CSMD1 Targeted by MicroRNA-10b Drives Gastric Cancer Progression through the NF-κB Pathway. International Journal of Biological Sciences, 15, 2075-2086. [Google Scholar] [CrossRef] [PubMed]
[21] Nishidoi, H. and Koga, S. (1987) Clinicopathological Study of Gastric Cancer with Bone Metastasis. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 14, 1717-1722.
[22] Turkoz, F.P., Solak, M., Kilickap, S., Ulas, A., Esbah, O., Oksuzoglu, B., et al. (2014) Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival. Journal of Gastric Cancer, 14, 164-172. [Google Scholar] [CrossRef] [PubMed]
[23] 龙敏. 胃癌骨转移临床病理特征及其预后因素分析[D]: [硕士学位论文]. 南昌: 南昌大学, 2019.
[24] Lee, J., Lim, T., Uhm, J.E., Park, K.W., Park, S.H., Lee, S.C., et al. (2007) Prognostic Model to Predict Survival Following First-Line Chemotherapy in Patients with Metastatic Gastric Adenocarcinoma. Annals of Oncology, 18, 886-891. [Google Scholar] [CrossRef] [PubMed]
[25] 张高嘉, 王俊锋, 李万荣, 张云鹏, 沈志祥. 胃癌骨转移的临床特点[J]. 中国肿瘤临床, 2015, 42(9): 457-459.
[26] Chen, C., He, W., Huang, J., Wang, B., Li, H., Cai, Q., Su, F., Bi, J., Liu, H., Zhang, B., Jiang, N., Zhong, G., Zhao, Y., Dong, W. and Lin, T. (2018) LNMAT1 Promotes Lymphatic Metastasis of Bladder Cancer Via CCL2 Dependent Macrophage Recruitment. Nature Communications, 9, Article No. 3826. [Google Scholar] [CrossRef] [PubMed]
[27] Yu, T., Wang, L.N., Li, W., Zuo, Q.F., Li, M.M., Zou, Q.M. and Xiao, B. (2018) Downregulation of MiR-491-5p Promotes Gastric Cancer Metastasis by Regulating SNAIL and FGFR4. Cancer Science, 109, 1393-1403. [Google Scholar] [CrossRef] [PubMed]
[28] Xie, M., Nie, F.Q., Sun, M., Xia, R., Liu, Y.W., Zhou, P., De, W. and Liu, X.H. (2015) Decreased Long Noncoding RNA SPRY4-IT1 Contributing to Gastric Cancer Cell Metastasis Partly via Affecting Epithelial-Mesenchymal Transition. Journal of Translational Medicine, 13, Article No. 250. [Google Scholar] [CrossRef] [PubMed]
[29] Leporini, C., Ammendola, M., Marech, I., Sammarco, G., Sacco, R., Gadaleta, C.D., Oakley, C., Russo, E., De Sarro, G. and Ranieri, G. (2015) Targeting Mast Cells in Gastric Cancer with Special Reference to Bone Metastases. World Journal of Gastroenterology, 21, 10493-10501. [Google Scholar] [CrossRef] [PubMed]
[30] Saito, H., Fukumoto, Y., Osaki, T., et al. (2006) Distinct Recurrence Pattern and Outcome of Adenocarcinoma of the Gastric Cardia in Comparison with Carcinoma of Other Regions of the Stomach. World Journal of Surgery, 30, 1864-1869. [Google Scholar] [CrossRef] [PubMed]
[31] Zhao, B., Zhang, J., Zhang, J., Luo, R., Wang, Z., Xu, H. and Huang, B. (2018) Assessment of the 8th Edition of TNM Staging System for Gastric Cancer: The Results from the SEER and a Single-Institution Database. Future Oncology, 14, 3023-3035. [Google Scholar] [CrossRef] [PubMed]
[32] Kooby, D.A., Suriawinata, A., Klimstra, D.S., Brennan, M.F. and Karpeh, M.S. (2003) Biologic Predictors of Survival in Node-Negative Gastric Cancer. Annals of Surgery, 237, 828-835. [Google Scholar] [CrossRef] 
[33] Huang, K.H., Chen, J.H., Wu, C.W., et al. (2009) Factors Affecting Recurrence in Node-Negative Advanced Gastric Cancer. Journal of Gastroenterology and Hepatology, 24, 1522-1526. [Google Scholar] [CrossRef] [PubMed]
[34] Liu, Y., Chen, X.H., Meng, X.H., et al. (2012) Multivariate Prognostic Study on Node-Positive Gastric Cancer: Is Tumor Size a Prognostic Indicator? Hepatogastroenterology, 59, 623-626. [Google Scholar] [CrossRef] [PubMed]
[35] York, J.E., et al. (1999) Gastric Cancer and Metastasis to the Brai. Annals of Surgical Oncology, 6, 771-776. [Google Scholar] [CrossRef] [PubMed]
[36] Go Pauline, H., et al. (2011) Gastrointestinal Cancer and Brain Metastasis: A Rare and Ominous Sign. Cancer, 117, 3630-3640. [Google Scholar] [CrossRef] [PubMed]
[37] Oh, S.Y., Lee, S.J., Lee, J., et al. (2009) Gastric Leptomeningeal Carcinomatosis: Multi-Center Retrospective Analysis of 54 Cases. World Journal of Gastroenterology, 15, 5086-5090. [Google Scholar] [CrossRef] [PubMed]
[38] Kasakura, Y., Fujii, M., Mochizuki, F., Suzuki, T. and Takahashi, T. (2000) Clinicopathological Study of Brain Metastasis in Gastric Cancer Patients. Surgery Today, 30, 485-490. [Google Scholar] [CrossRef] [PubMed]
[39] Luo, H., Peng, L., Wang, N., Zhang, J., Zheng, X., Sun, Y., Fan, C. and Ge, H. (2018) Early Brain Metastasis of Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy Followed by Surgery: A Case Report and Literature Review. Cancer Biology & Therapy, 19, 875-878. [Google Scholar] [CrossRef] [PubMed]
[40] Minn, Y.K., Lee, D.H., Hyung, W.J., Kim, J.E., Choi, J., Yang, S.H., Song, H., Lim, B.J. and Kim, S.H. (2014) MicroRNA-200 Family Members and ZEB2 Are Associated with Brain Metastasis in Gastric Adenocarcinoma. International Journal of Oncology, 45, 2403-2410. [Google Scholar] [CrossRef] [PubMed]
[41] Sakurai, K., Muguruma, K., Murata, A., Toyokawa, T., Amano, R., Kubo, N., Tanaka, H., Yashiro, M., Maeda, K., Ohira, M. and Hirakawa, K. (2014) Early Gastric Cancer with Suspected Brain Metastasis Arising Eight Years after Curative Resection: A Case Report. BMC Research Notes, 19, Article No. 818818. [Google Scholar] [CrossRef] [PubMed]
[42] Gregory, P.A., Bert, A.G., Paterson, E.L., et al. (2008) The MiR-200 Family and MiR-205 Regulate Epithelial to Mesenchymal Transition by Targeting ZEB1 and SIP1. Nature Cell Biology, 10, 593-601. [Google Scholar] [CrossRef] [PubMed]
[43] Cong, N., Du, P., Zhang, A., et al. (2013) Downregulated MicroRNA-200a Promotes EMT and Tumor Growth through the Wnt/β-Catenin Pathway by Targeting the E-Cadherin Repressors ZEB1/ZEB2 in Gastric Adenocarcinoma. Oncology Reports, 29, 1579-1587. [Google Scholar] [CrossRef] [PubMed]
[44] Dai, Y.H., Tang, Y.P., Zhu, H.Y., et al. (2012) ZEB2 Promotes the Metastasis of Gastric Cancer and Modulates Epithelial Mesenchymal Transition of Gastric Cancer Cells. Digestive Diseases and Sciences, 57, 1253-1260. [Google Scholar] [CrossRef] [PubMed]
[45] Jun, K.H., Lee, J.E., Kim, S.H., Jung, J.H., Choi, H.J., Kim, Y.I., Chin, H.M. and Yang, S.H. (2015) Clinicopathological Significance of N-Cadherin and VEGF in Advanced Gastric Cancer Brain Metastasis and the Effects of Metformin in Preclinical Models. Oncology Reports, 34, 2047-2053. [Google Scholar] [CrossRef] [PubMed]
[46] Cavanna, L., Seghini, P., Di Nunzio, C., Orlandi, E., Michieletti, E., Stroppa, E.M., Mordenti, P., Citterio, C., Vecchia, S. and Zangrandi, A. (2018) Gastric Cancer with Brain Metastasis and the Role of Human Epidermal Growth Factor 2 Status. Oncology Letters, 15, 5787-5791. [Google Scholar] [CrossRef] [PubMed]
[47] Yang, G.L., Luo, T.H., Zhang, H.Q., Ling, C.Q. and Li, B. (2016) A Case Report of Gastric Cancer with Brain Metastasis: Rare Peripheral Nervous System Symptoms. Oncology Letters, 11, 2893-2895. [Google Scholar] [CrossRef] [PubMed]
[48] Cinar, P., Calkins, S.M., Venook, A.P. and Kelley, R.K. (2014) Case Series of Patients with HER-2-Overexpressed Primary Metastatic Gastro-esophageal Adenocarcinoma. Anticancer Research, 34, 7357-7360.
[49] Choy, C., Ansari, K.I., Neman, J., Hsu, S., Duenas, M.J., Li, H., Vaidehi, N. and Jandial, R. (2017) Cooperation of Neurotrophin Receptor TrkB and HER-2 in Breast Cancer Cells Facilitates Brain Metastases. Breast Cancer Research, 19, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
[50] de Larco, J.E. and Todaro, G.J. (1978) Growth Factors from Murine Sarcoma Virus-Transformed Cells. Proceedings of the National Academy of Sciences of the United States of America, 75, 4001-4005. [Google Scholar] [CrossRef] [PubMed]
[51] Logullo, A.F., Nonogaki, S., Miguel, R.E., Kowalski, L.P., Nishimoto, I.N., Pasini, F.S., Federico, M.H., Brentani, R.R. and Brentani, M.M. (2003) Transforming Growth Factor Beta1 (TGFbeta1) Expression in Head and Neck Squamous Cell Carcinoma Patients as Related to Prognosis. Journal of Oral Pathology & Medicine, 32, 139-145. [Google Scholar] [CrossRef] [PubMed]
[52] Han, S.U., Kim, H.T., Seong, D.H., Kim, Y.S., Park, Y.S., Bang, Y.J., Yang, H.K. and Kim, S.J. (2004) Loss of the Smad3 Expression Increases Susceptibility to Tumorigenicity in Human Gastric Cancer. Oncogene, 23, 1333-1341. [Google Scholar] [CrossRef] [PubMed]
[53] 郑涛, 杨甲梅. 转化生长因子β信号通路在肝癌患者中的作用机制[J]. 中华肝胆外科杂志, 2016, 22(6): 425-428. [Google Scholar] [CrossRef] 
[54] 王肖泽, 王继见. 胃癌转移机制研究新进展[J]. 重庆医学, 2010, 39(4): 479-481.
[55] 陈德兴, 张洪伟. 胃癌肝转移治疗现状[J]. 中国实用外科杂志, 2019, 39(4): 382-384+390.

为你推荐